Palisade Bio (NASDAQ:PALI) stock is falling on Thursday after the clinical-stage biopharmaceutical company announced a share offering.
Palisade Bio is selling over 2.33 million shares of PALI stock through a registered direct offering. The company notes that gross proceeds from this sale will come to over $1.96 million. The buyers of these shares are institutional investors. Also, Ladenburg Thalmann & Co. is acting as the exclusive placement agent for the offering.
Palisade notes that this offering will take place on or about Sept. 11. The company will use the funds gained from the offering for working capital and general corporate purposes. Shares in the offering will be sold at market prices.
How This Affects PALI Stock
This registered direct offering has Palisade Bio increasing the total number of shares available on the market. Doing so will cause the stakes of current investors in the company to be diluted. Considering that effect, it makes sense that shares of PALI stock would fall on the news.
Today’s registered direct offering announcement also brings with it heavy trading of PALI stock. As of this writing, over 4.6 million shares have changed hands. For the record, that’s already well above its daily average trading volume of about 2.9 million shares.
PALI stock is down 45.5% as of Thursday morning.
Investors searching for more of the most recent stock market news today are in luck!
We’ve got all of the biggest stock market stories that investors need to know about on Thursday! That includes everything happening with shares of Dutch Bros (NYSE:BROS), ChargePoint (NYSE:CHPT) and GameStop (NYSE:GME) stock today. All of that news is ready to go at the following links!
More Thursday Stock Market News
- Why Is Dutch Bros (BROS) Stock Down 8% Today?
- ChargePoint Layoffs 2023: What to Know About the Latest CHPT Job Cuts
- GME Stock: Can GameStop Still Save Itself?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
